The effects of chitosan supplementation on body weight and body composition: a systematic review and meta-analysis of randomized controlled trials

References

• Ashraf, M. J., and P. Baweja. 2013. Obesity: The 'huge' problem in cardiovascular diseases. Missouri Medicine. 110 (6):499–504.
   PubMedGoogle Scholar
• Astrup, A., and S. Rossner. 2000. Lessons from obesity management programmes: Greater initial weight loss improves long-term maintenance. Obesity Reviews. 1 (1):17–9. doi: 10.1046/j.1467-789x.2000.00004.x.
   PubMedGoogle Scholar
• Blissmer, B., D. Riebe, G. Dye, L. Ruggiero, G. Greene, and M. Caldwell. 2006. Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: Intervention and 24 month follow-up effects. Health and Quality of Life Outcomes 4:43.
   PubMed Web of Science ®Google Scholar
• Bokura, H., and S. Kobayashi. 2003. Chitosan decreases total cholesterol in women: A randomized, double-blind, placebo-controlled trial. European Journal of Clinical Nutrition 57 (5):721–5. doi: 10.1038/sj.ejcn.1601603.
   PubMed Web of Science ®Google Scholar
• Bueter, C. L., C. A. Specht, and S. M. Levitz. 2013. Innate sensing of chitin and chitosan. PLoS Pathogens 9 (1):e1003080. doi: 10.1371/journal.ppat.1003080.
   PubMed Web of Science ®Google Scholar
• Cummings, D. E., and M. W. Schwartz. 2003. Genetics and pathophysiology of human obesity. Annual Review of Medicine 54:453–71. doi: 10.1146/annurev.med.54.101601.152403.
   PubMed Web of Science ®Google Scholar
• Czernichow, S., C. M. Lee, F. Barzi, J. R. Greenfield, L. A. Baur, J. Chalmers, M. Woodward, and R. R. Huxley. 2010. Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: A meta-analysis of randomized controlled trials. Obesity Reviews 11 (2):150–8. doi: 10.1111/j.1467-789X.2009.00620.x.
   PubMed Web of Science ®Google Scholar
• Deuchi, K., O. Kanauchi, Y. Imasato, and E. Kobayashi. 1995. Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet. Bioscience, Biotechnology, and Biochemistry 59 (5):781–5.
   PubMed Web of Science ®Google Scholar
• Egger, M., G. Davey Smith, M. Schneider, and C. Minder. 1997. Bias in meta-analysis detected by a simple, graphical test. Bmj (Clinical Research ed.) 315 (7109):629–34.
   PubMed Web of Science ®Google Scholar
• Guh, D. P., W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis. 2009. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 9:88.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gonzalez, S. O., M. Gonzalez-Ortiz, E. Martinez-Abundis, and J. A. Robles-Cervantes. 2010. Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects. Nutrition Research 30:392–5. doi: 10.1016/j.nutres.2010.06.005.
   PubMed Web of Science ®Google Scholar
• Hession, M., C. Rolland, U. Kulkarni, A. Wise, and J. Broom. 2009. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obesity Reviews 10 (1):36–50. doi: 10.1111/j.1467-789X.2008.00518.x.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., and S. Green. 2011. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. (updated March 2011). http://handbook.cochrane.org/.
   Google Scholar
• Higgins, J. P., S. G. Thompson, J. J. Deeks, and D. G. Altman. 2003. Measuring inconsistency in meta-analyses. Bmj (Clinical Research ed.) 327 (7414):557–60. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Ho, S. C., E. S. Tai, P. H. Eng, C. E. Tan, and A. C. Fok. 2001. In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Medical Journal 42 (1):6–10.
   PubMedGoogle Scholar
• Huang, H., Y. Zou, and H. Chi. 2017. Quantitative assessment of the effects of chitosan intervention on blood pressure control. Drug Design, Development and Therapy 12:67–75. doi: 10.2147/DDDT.S148064.
   PubMed Web of Science ®Google Scholar
• Huang, H., Y. Zou, H. Chi, and D. Liao. 2018. Lipid-modifying effects of chitosan supplementation in humans: A pooled analysis with trial sequential analysis. Molecular Nutrition & Food Research 62 (8):1700842. doi: 10.1002/mnfr.201700842.
   Web of Science ®Google Scholar
• Jull, A. B., C. Ni Mhurchu, D. A. Bennett, C. A. Dunshea-Mooij, and A. Rodgers. 2008. Chitosan for overweight or obesity. Cochrane Database of Systematic Reviews 16 (3): CD003892.
   PubMed Web of Science ®Google Scholar
• Jung, E. Y., S. C. Jun, U. J. Chang, and H. J. Suh. 2014. L-ascorbic acid addition to chitosan reduces body weight in overweight women. International Journal for Vitamin and Nutrition Research 84 (1–2):5–11. doi: 10.1024/0300-9831/a000187.
   PubMed Web of Science ®Google Scholar
• Kaats, G. R., J. E. Michalek, and H. G. Preuss. 2006. Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol. Journal of the American College of Nutrition 25 (5):389–94. doi: 10.1080/07315724.2006.10719550.
   PubMed Web of Science ®Google Scholar
• Karadeniz, F., and S. K. Kim. 2014. Antidiabetic activities of chitosan and its derivatives: A mini review. Advances in Food and Nutrition Research 73:33–44. doi: 10.1016/B978-0-12-800268-1.00003-2.
   PubMedGoogle Scholar
• Kelly, T., W. Yang, C. S. Chen, K. Reynolds, and J. He. 2008. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity (2005) 32 (9):1431–7. doi: 10.1038/ijo.2008.102.
   PubMed Web of Science ®Google Scholar
• Kim, H. J., H. Y. Ahn, J. H. Kwak, D. Y. Shin, Y. I. Kwon, C. G. Oh, and J. H. Lee. 2014. The effects of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with prediabetes. Food & Function 5 (10):2662–9. doi: 10.1039/c4fo00469h.
   PubMed Web of Science ®Google Scholar
• Kovacs, E. M., and D. J. Mela. 2006. Metabolically active functional food ingredients for weight control. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 7 (1):59–78. doi: 10.1111/j.1467-789X.2006.00203.x.
   PubMed Web of Science ®Google Scholar
• Lavie, C. J., R. V. Milani, and H. O. Ventura. 2009. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology 53 (21):1925–32. doi: 10.1016/j.jacc.2008.12.068.
   PubMed Web of Science ®Google Scholar
• Lehtimäki, T., S. Metso, R. Ylitalo, R. Rontu, M. Nikkil, E. Wuolijoki, and P. Ylitalo. 2005. Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: A long-term placebo-controlled trial in hypercholesterolaemic volunteers. Basic Clinical Pharmacology & Toxicology 97 (2):98–103. doi: 10.1111/j.1742-7843.2005.pto_111.x.
   PubMed Web of Science ®Google Scholar
• Liao, F. H., M. J. Shieh, N. C. Chang, and Y. W. Chien. 2007. Chitosan supplementation lowers serum lipids and maintains normal calcium, magnesium, and iron status in hyperlipidemic patients. Nutrition Research 27 (3):146–51. doi: 10.1016/j.nutres.2007.01.009.
   Web of Science ®Google Scholar
• Ma, C., A. Avenell, M. Bolland, J. Hudson, F. Stewart, C. Robertson, P. Sharma, C. Fraser, and G. MacLennan. 2017. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: Systematic review and meta-analysis. BMJ 359:j4849.
   PubMedGoogle Scholar
• Macchi, G. 1996. A new approach to the treatment of obesity: Chitosan’s effects on body weight reduction and plasma cholesterol’s levels. Acta Pharmacologica et Toxicologica 17:301–20.
   Google Scholar
• Maharlouei, N., R. Tabrizi, K. B. Lankarani, A. Rezaianzadeh, M. Akbari, F. Kolahdooz, M. Rahimi, F. Keneshlou, and Z. Asemi. 2018. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. Advance online publication. doi: 10.1080/10408398.2018.1427044.
   PubMed Web of Science ®Google Scholar
• Metso, S., R. Ylitalo, M. Nikkil, E. Wuolijoki, P. Ylitalo, and T. Lehtimäki. 2003. The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: A randomised placebo-controlled double-blind crossover trial in healthy men and women. European Journal of Clinical Pharmacology 59 (10):741–6. doi: 10.1007/s00228-003-0691-2.
   PubMed Web of Science ®Google Scholar
• Mhurchu, C. N., S. D. Poppitt, A. T. McGill, F. E. Leahy, D. A. Bennett, R. B. Lin, D. Ormrod, L. Ward, C. Strik, and A. Rodgers. 2004. The effect of the dietary supplement, chitosan, on body weight: A randomised controlled trial in 250 overweight and obese adults. International Journal of Obesity 28 (9):1149–56. doi: 10.1038/sj.ijo.0802693.
   Web of Science ®Google Scholar
• Misra, A., P. Chowbey, B. M. Makkar, N. K. Vikram, J. S. Wasir, D. Chadha, S. R. Joshi, S. Sadikot, R. Gupta, S. Gulati, and Y. P. Munjal. 2009. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. Journal of Association of Physicians of India 57:163–70.
   PubMedGoogle Scholar
• Mohammadi-Sartang, M., Z. Mazloom, H. Raeisi-Dehkordi, R. Barati-Boldaji, N. Bellissimo, and J. O. Totosy de Zepetnek. 2017. The effect of flaxseed supplementation on body weight and body composition: A systematic review and meta-analysis of 45 randomized placebo-controlled trials. Obesity Reviews 18 (9):1096–107. doi: 10.1111/obr.12550.
   PubMed Web of Science ®Google Scholar
• Morton, S. C., J. L. Adams, M. J. Suttorp, and P. G. Shekelle. 2004. Meta-regression approaches: What, why, when, and how? Rockville MD: Agency for Healthcare Research and Quality (US).
   Google Scholar
• Pan, H., C. Fu, L. Huang, Y. Jiang, X. Deng, J. Guo, and Z. Su. 2018. Anti-obesity effect of chitosan oligosaccharide capsules (COSCs) in obese rats by ameliorating leptin resistance and adipogenesis. Marine Drugs 16:E198.
   PubMed Web of Science ®Google Scholar
• Pittler, M. H., N. C. Abbot, E. F. Harkness, and E. Ernst. 1999. Randomized, double-blind trial of chitosan for body weight reduction. European Journal of Clinical Nutrition 53 (5):379–81.
   PubMed Web of Science ®Google Scholar
• Pooyandjoo, M., M. Nouhi, S. Shab-Bidar, K. Djafarian, and A. Olyaeemanesh. 2016. The effect of (L-)carnitine on weight loss in adults: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews 17 (10):970–6. doi: 10.1111/obr.12436.
   PubMed Web of Science ®Google Scholar
• Pranantyo, D., L. Q. Xu, E. T. Kang, and M. B. Chan-Park. 2018. Chitosan-based peptidopolysaccharides as cationic antimicrobial agents and antibacterial coatings. Biomacromolecules 19 (6):2156–65. doi: 10.1021/acs.biomac.8b00270.
   PubMed Web of Science ®Google Scholar
• Rahman, M. A., S. G. Kumar, and J. W. Yun. 2010. Proteome analysis in adipose tissue of ob/ob mice in response to chitosan oligosaccharides treatment. Biotechnology and Bioprocess Engineering 15 (4):559–71. doi: 10.1007/s12257-009-3135-8.
   Web of Science ®Google Scholar
• Santas, J., E. Lazaro, and J. Cune. 2017. Effect of a polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGo(R)) in body weight loss: Randomised, double-blind, placebo-controlled clinical trial in overweight and obese adults. Journal of the Science of Food and Agriculture 97 (12):4250–7. doi: 10.1002/jsfa.8301.
   PubMed Web of Science ®Google Scholar
• Schiller, R. N., E. Barrager, A. G. Schauss, and E. J. Nichols. 2001. A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. JANA 4:42–9.
   Google Scholar
• Snow, V., P. Barry, N. Fitterman, A. Qaseem, K. Weiss, Clinical Efficacy Assessment Subcommittee of the American College of Physicians. 2005. Pharmacologic and surgical management of obesity in primary care: A clinical practice guideline from the American College of Physicians. Ann Intern Med 142 (7):525–31.
   PubMed Web of Science ®Google Scholar
• Trigueros, L., S. Pena, A. V. Ugidos, E. Sayas-Barbera, J. A. Perez-Alvarez, and E. Sendra. 2013. Food ingredients as anti-obesity agents: A review. Critical Reviews in Food Science and Nutrition 53 (9):929–42. doi: 10.1080/10408398.2011.574215.
   PubMed Web of Science ®Google Scholar
• Trivedi, V. R., M. C. Satia, A. Deschamps, V. Maquet, R. B. Shah, P. H. Zinzuwadia, and J. V. Trivedi. 2016. Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction. Nutrition Journal 15:3.
   PubMed Web of Science ®Google Scholar
• Van Gaal, L. F., M. A. Wauters, and I. H. De Leeuw. 1997. The beneficial effects of modest weight loss on cardiovascular risk factors. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity 21(Suppl 1):S5–S9.
   PubMed Web of Science ®Google Scholar
• Van Gaal, L. F., I. L. Mertens, and D. Ballaux. 2005. What is the relationship between risk factor reduction and degree of weight loss? European Heart Journal Supplements 7S:21–6.
   Google Scholar
• Walsh, A. M., T. Sweeney, B. Bahar, and J. V. O’Doherty. 2013. Multi-functional roles of chitosan as a potential protective agent against obesity. PLoS One 8 (1):e53828. doi: 10.1371/journal.pone.0053828.
   PubMed Web of Science ®Google Scholar
• Wenger, N. K. 2014. Prevention of cardiovascular disease: Highlights for the clinician of the 2013 American college of cardiology/American heart association guidelines. Clinical Cardiology 37 (4):239–51. doi: 10.1002/clc.22264.
   PubMed Web of Science ®Google Scholar
• Wing, R. R., W. Lang, T. A. Wadden, M. Safford, W. C. Knowler, A. G. Bertoni, J. O. Hill, F. L. Brancati, A. Peters, and L. Wagenknecht. 2011. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34 (7):1481–6. doi: 10.2337/dc10-2415.
   PubMed Web of Science ®Google Scholar
• Zacour, A. C., M. E. Silva, P. R. Cecon, E. A. Bambirra, and E. C. Vieira. 1992. Effect of dietary chitin on cholesterol absorption and metabolism in rats. Journal of Nutritional Science and Vitaminology 38 (6):609–13.
   PubMed Web of Science ®Google Scholar
• Zhang, J., J. Liu, L. Li, and W. Xia. 2008. Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets. Nutrition Research 28 (6):383–90. doi: 10.1016/j.nutres.2007.12.013.
   PubMed Web of Science ®Google Scholar
• Zahorska-Markiewicz, B., M. Krotkiewski, M. Olszanecka-Glinianowicz, and A. Zurakowski. 2002. [Effect of chitosan in complex management of obesity]. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13 (74):129–32.
   PubMedGoogle Scholar
• Zomer, E., K. Gurusamy, R. Leach, C. Trimmer, T. Lobstein, S. Morris, W. P. James, and N. Finer. 2016. Interventions that cause weight loss and the impact on cardiovascular risk factors: A systematic review and meta-analysis. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 17 (10):1001–11. doi: 10.1111/obr.12433.
   PubMed Web of Science ®Google Scholar